Home

Menu

Loading wiki pages...

View
Wiki Version:
<p>Author: Joshua Cohen</p> <p>Background: We developed a model to evaluate treatments for early-stage Hodgkin Lymphoma (HL). The purpose of the model is to project long-term impacts of alternative treatments for HL, taking into account late effects associated with HL treatment.</p> <p>Methods: INTERVENTIONS: (1) Chemotherapy alone, and (2) Chemotherapy plus radiation therapy. POPULATION: two prototypical patients: "Patient 1: a 25-year-old male with favorable ESHL (stage IA); Patient 2: a 25-year-old female with unfavorable ESHL (stage IIB)" (from abstract). OUTCOMES: QALYs and LYs.</p> <p>Results: For Patient 1, CMT was superior to CA (CMT incremental gain = 0.11 QALYs, 0.21 LYs). For Patient 2, CA was superior to CMT (CA incremental gain = 0.37 QALYs, 0.92 LYs).</p> <p>Conclusion: Therapy benefits depend on patient characteristics.</p>
OSF does not support the use of Internet Explorer. For optimal performance, please switch to another browser.
Accept
This website relies on cookies to help provide a better user experience. By clicking Accept or continuing to use the site, you agree. For more information, see our Privacy Policy and information on cookie use.
Accept
×

Start managing your projects on the OSF today.

Free and easy to use, the Open Science Framework supports the entire research lifecycle: planning, execution, reporting, archiving, and discovery.